KRYS vs. AEVA

Last updated Jun 9, 2026

KRYS (Krystal Biotech, Inc.) and AEVA (Aeva Technologies, Inc.) are both stocks. KRYS operates in Biotechnology (Healthcare), while AEVA operates in Auto Parts (Consumer Cyclical). Over the past 5 years, KRYS returned 35.77%/yr vs -16.40%/yr for AEVA. At a 0.27 correlation, their price movements are largely independent.

Performance

KRYS vs. AEVA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Krystal Biotech, Inc. (KRYS) and Aeva Technologies, Inc. (AEVA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, KRYS achieves a 22.40% return, which is significantly lower than AEVA's 73.87% return.

KRYS

• 1D: 0.25%
• 1M: -1.29%
• YTD: 22.40%
• 6M: 28.93%
• 1Y: 120.36%
• 3Y*: 32.77%
• 5Y*: 35.77%
• 10Y*: —

AEVA

• 1D: 0.35%
• 1M: 70.15%
• YTD: 73.87%
• 6M: 53.02%
• 1Y: 10.48%
• 3Y*: 49.22%
• 5Y*: -16.40%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

KRYS vs. AEVA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
KRYS Krystal Biotech, Inc.	22.40%	57.37%	26.28%	56.60%	13.25%	16.58%	9.09%
AEVA Aeva Technologies, Inc.	73.87%	179.58%	25.38%	-44.29%	-82.01%	-48.01%	51.46%

Correlation

The correlation between KRYS and AEVA is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.20
Correlation (3Y) Calculated over the trailing 3-year period	0.22
Correlation (5Y) Calculated over the trailing 5-year period	0.29
Correlation (All Time) Calculated using the full available price history since Feb 27, 2020	0.27

Fundamentals

Market Cap KRYS : $9.21B AEVA : $1.45B
EPS KRYS : $7.50 AEVA : -$2.52
PS Ratio KRYS : 21.70 AEVA : 63.51
Total Revenue (TTM) KRYS : $417.30M AEVA : $20.97M
Gross Profit (TTM) KRYS : $387.24M AEVA : $971.00K
EBITDA (TTM) KRYS : $185.45M AEVA : $21.17M

Return for Risk

KRYS vs. AEVA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KRYS

KRYS Risk / Return Rank: 94
KRYS Sharpe Ratio Rank: 96
KRYS Sortino Ratio Rank: 92
KRYS Omega Ratio Rank: 92
KRYS Calmar Ratio Rank: 96
KRYS Martin Ratio Rank: 96

AEVA

AEVA Risk / Return Rank: 49
AEVA Sharpe Ratio Rank: 46
AEVA Sortino Ratio Rank: 55
AEVA Omega Ratio Rank: 53
AEVA Calmar Ratio Rank: 46
AEVA Martin Ratio Rank: 44

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

KRYS vs. AEVA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Krystal Biotech, Inc. (KRYS) and Aeva Technologies, Inc. (AEVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	KRYS	AEVA	Difference
Sharpe ratio: Return per unit of total volatility	3.12	0.09	+3.03
Sortino ratio: Return per unit of downside risk	3.42	1.00	+2.42
Omega ratio: Gain probability vs. loss probability	1.47	1.12	+0.35
Calmar ratio: Return relative to maximum drawdown	7.59	0.14	+7.45
Martin ratio: Return relative to average drawdown	19.64	0.19	+19.45
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

KRYS vs. AEVA - Sharpe Ratio Comparison

The current KRYS Sharpe Ratio is 3.12, which is higher than the AEVA Sharpe Ratio of 0.09. The chart below compares the historical Sharpe Ratios of KRYS and AEVA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	KRYS	AEVA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	3.12	0.09	+3.03
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.47	-0.17	+0.64
Sharpe Ratio (All Time) Calculated using the full available price history	0.63	-0.12	+0.76

Drawdowns

KRYS vs. AEVA - Drawdown Comparison

The maximum KRYS drawdown since its inception was -53.42%, smaller than the maximum AEVA drawdown of -97.71%. Use the drawdown chart below to compare losses from any high point for KRYS and AEVA.

Drawdown Indicators

	KRYS	AEVA	Difference
Max Drawdown Largest peak-to-trough decline	-53.42%	-97.71%	+44.29%
Max Drawdown (1Y) Largest decline over 1 year	-15.94%	-75.68%	+59.74%
Max Drawdown (3Y) Largest decline over 3 years	-42.26%	-75.68%	+33.42%
Max Drawdown (5Y) Largest decline over 5 years	-44.55%	-96.02%	+51.47%
Current Drawdown Current decline from peak	-4.60%	-76.91%	+72.31%
Average Drawdown Average peak-to-trough decline	-16.20%	-70.68%	+54.48%
Ulcer Index Depth and duration of drawdowns from previous peaks	6.15%	55.91%	-49.76%

Volatility

KRYS vs. AEVA - Volatility Comparison

The current volatility for Krystal Biotech, Inc. (KRYS) is 10.25%, while Aeva Technologies, Inc. (AEVA) has a volatility of 39.11%. This indicates that KRYS experiences smaller price fluctuations and is considered to be less risky than AEVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	KRYS	AEVA	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.25%	39.11%	-28.86%
Volatility (6M) Calculated over the trailing 6-month period	27.29%	78.74%	-51.45%
Volatility (1Y) Calculated over the trailing 1-year period	38.91%	114.82%	-75.91%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	76.38%	97.00%	-20.62%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	74.19%	91.35%	-17.16%

Dividends

KRYS vs. AEVA - Dividend Comparison

Neither KRYS nor AEVA has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both KRYS and AEVA in my portfolio?

KRYS and AEVA have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, KRYS or AEVA?

AEVA has higher volatility (39.11%) compared to KRYS (10.25%). In terms of maximum drawdown, KRYS dropped -53.42% vs AEVA's -97.71%.

Which has better risk-adjusted returns?

KRYS currently has the higher Sharpe Ratio (3.12 vs 0.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.